Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

41 results about "Reduced nicotinamide-adenine dinucleotide" patented technology

Method and kit for stably detecting sialic acid by enzyme method

The invention relates to a method and a kit for stably detecting sialic acid by an enzyme method. The method comprises the following steps of: generating N-acetylneuraminic acid from bound sialic acid under the catalysis of neuraminic acid aldolase; transforming the N-acetylneuraminic acid into N-acetylmannosamine under the catalysis of neuraminidase; reacting the product with mannosamine dehydrogenase and nicotinamide adenine dinucleotide (NAD) to generate reduced nicotinamide adenine dinucleotide (NADH); and measuring the sialic acid content by detecting the amount of the generated NADH. The invention also relates to the kit prepared according to the method. The method and the kit are conveniently and quickly used, the sialic acid is not required to be redissolved by dissolving liquid, is stable for a long time and has small inter-bottle variation, the method and the kit are suitable for various biochemical analyzers, secondary pollution is avoided, and a production process method is simplified.
Owner:BEIJING STRONG BIOTECH INC

Ribitol dehydrogenase (RDH) derived from Klebsiella oxytoca, and coding gene and application thereof

The invention discloses a ribitol dehydrogenase (RDH) derived from Klebsiella oxytoca G4A4CGMCC No.7662, and realizes expression thereof in Escherichia coli. The experiment proves that the enzyme can realize the biotransformation production of allitol, and D-allulose can be converted into the functional rare sugar alcohol (allitol) with high conversion rate (96% or above at most) and less pollution; and an NADH (reduced nicotinamide adenine dinucleotide) regeneration system is added in the conversion process, and the NAD (nicotinamide adenine dinucleotide) consumption is low, thereby greatly lowering the cost. The allitol can be used in multiple fields such as preparation of pharmaceuticals (such as diabetes treatment medicaments and the like), health products and other raw materials of rare sugar and the like, and has wide application prospects.
Owner:TIANJIN INST OF IND BIOTECH CHINESE ACADEMY OF SCI

Preparation method of urea determination reagent ball, reagent ball and detection chip

PendingCN111707631AWide effective test rangeHigh maximum concentrationPreparing sample for investigationLaboratory glasswaresGlutaric acidFreeze-drying
The invention relates to the technical field of urea detection, in particular to a preparation method of a urea determination reagent ball, the reagent ball and a detection chip. The embodiment of theinvention provides a preparation method of a urea determination reagent ball. The method comprises the following steps of mixing a certain dosage of buffer solution, disodium ethylene diamine tetraacetate, alpha-ketoglutarate, glutamate dehydrogenase, urease, reduced nicotinamide adenine dinucleotide and excipient with water to form a mixed solution, dropwise adding the mixed solution into liquidnitrogen to enable liquid drops of the mixed solution to form ice balls, and freeze-drying the ice balls to obtain spherical urea determination reagent balls. The urea determination reagent ball prepared by the method has good thermal stability, can be stored for 8 days at a high temperature of 37 DEG C, is not easy to deteriorate in the storage process, has a wide effective test range on urea inblood, and can test the highest concentration of blood urea as high as 35mmol / L.
Owner:GENRUI BIOTECH INC

Method for determining alcohol concentration by using enzyme cycling method and alcohol determination kit

The invention provides a method for determining alcohol concentration by using an enzyme cycling method and an alcohol determination kit. The method comprises the following steps of: generating reduced nicotinamide adenine dinucleotide I by using nicotinamide adenine dinucleotide I and alcohol under the action of alcohol dehydrogenase, reacting the reduced nicotinamide adenine dinucleotide I with oxidized iodonitrotetrazolium (INT) under the action of diaphorase to generate red reduced INT, detecting a change in the absorbance of a final reactant, and then calculating the alcohol concentration of a sample. The kit consists of the following components: 0.05 to 0.5M of a buffer solution, 0.1 to 10g / L of a stabilizer, 0.05 to 10g / L of nicotinamide adenine dinucleotide I, 0.5 to 50KU / L of alcohol dehydrogenase, 0.05 to 50KU / L of diaphorase, 0.1 to 10g / L of oxidized INT and 0.1 to 10g / L of a preservative. The method is high in reaction specificity, detection specificity and sensitivity, wide in linear range and low in cost; and the kit is high in stability and accuracy.
Owner:NINGBO MEDICAL SYSTEM BIOTECHNOLOGY CO LTD

Metabolic-based methods for modulating gene expression

This invention provides methods for modulating cellular gene expression for genes operably linked to an NRSE element that is recognized by an NRSF transcriptional repressor, by changing the concentration of reduced nicotinamide adenine dinucleotide (NADH) in the cell.
Owner:WISCONSIN ALUMNI RES FOUND

Method for continuously catalyzing and synthesizing ATS-7 by immobilized enzyme fluidization bed

The invention belongs to the field of pharmaceutical and chemical industry, and particularly relates to a method for continuously catalyzing and synthesizing ATS-7 by an immobilized enzyme fluidization bed. Mixed liquid of glucose and a nicotinamide adenine dinucleotide phosphate (NADP+) generates reduced nicotinamide adenine dinucleotide phosphate (NADPH) through a GDH (glutamate dehydrogenase) bed, and mixed solution of ATS-6 and generated NADPH is implemented through a CR fluidized bed, so that the ATS-7 is continuously catalyzed and synthesized by the immobilized enzyme fluidization bed. By the continuous reaction catalysis method of the immobilized enzyme fluidization bed, enzyme catalyzing efficiency is improved; enzyme utilization rate is increased, the catalytic efficiency of the immobilized enzyme is improved by 3.1-4.2 times as compared with that of traditional free enzyme, reaction processes can be controlled by independently adjusting different sample feeding flow speed, the immobilized enzyme cannot easily fall off, continuously catalyzing reaction can be achieved, the immobilized enzyme and a product are conveniently separated, the yield of the product is improved, and purification steps are simplified, and industrialization is more facilitated.
Owner:JIANGSU UNIV OF TECH

Method for rapidly determining L-glutamic acid in food

The present invention relates to a method for rapidly determining the L-glutamic acid in food. The method comprises: grinding or mincing a solid or semi-solid sample by using a suitable tool, weighing a proper amount of the grinded or minced sample, adding an appropriate solvent, homogenizing, carrying out centrifuged separation, and filtering to obtain a free L-glutamic acid extraction liquid, or carrying out protein hydrolysis to obtain the L-glutamic acid extraction liquid constituting the protein structure (the liquid sample is directly filtered without the pretreatment); properly diluting the sample extraction liquid, and adjusting the pH value to 8.6; reducing nicotinamide adenine dinucleotide (NAD<+>) into nicotinamide adenine dinucleotide (NADH) in the presence of glutamate dehydrogenase(GIDH) through the L-glutamic acid of the sample detection liquid, and carrying out a reaction on the NADH and iodonitrotrtrazolium chloride (INT) under the effect of diaphorase to generate formazan; and determining the absorption peak of the formazan at 490 nm by using a light-absorption microplate reader, and calculating the L-glutamic acid content in the sample according to the absorption value of the formazan by using an external standard method. According to the present invention, the detection method has characteristics of simple operation, good accuracy, fastness, high throughput, easy popularization, and the like.
Owner:CENT TESTING INT GRP CO LTD

Method of stabilizing reduced nicotinamide adenine dinucleotide or reduced nicotinamide adenine dinucleotide phosphate

It is an object of the present invention to provide a method of stabilizing reduced nicotinamide adenine dinucleotide or reduced nicotinamide adenine dinucleotide phosphate [hereinafter abbreviated as NAD(P)H] and a preparation containing NAD(P)H stabilized by the method. As the method of stabilizing NAD(P)H, a method of adding astaxanthin to NAD(P)H is provided.
Owner:KYOWA HAKKO KOGYO CO LTD

Reagent for measuring alanine aminotransferase activity

InactiveUS7192727B2Microbiological testing/measurementLactate dehydrogenaseAminotransferase activity
A reagent for measuring an alanine aminotransferase activity comprising L-alanine, 2-oxoglutaric acid, lactate dehydrogenase, and reduced nicotinamide adenine dinucleotide, characterized by further comprising a substance having an activity of inhibiting lactate dehydrogenase activity is disclosed. Further, a method for measuring an alanine aminotransferase activity, characterized by bringing a sample to be analyzed, which may contain alanine aminotransferase, into contact with L-alanine, 2-oxoglutaric acid, lactate dehydrogenase, reduced nicotinamide adenine dinucleotide, and a substance having an activity of inhibiting a lactate dehydrogenase activity is disclosed. According to the reagent and method, an increase in the reagent blank reaction, i.e., an increase in the initial absorbance, can be suppressed.
Owner:MITSUBISHI CHEM MEDIENCE

Metabolic-based methods for modulating gene expression

This invention provides methods for modulating cellular gene expression for genes operably linked to an NRSE element that is recognized by an NRSF transcriptional repressor, by changing the concentration of reduced nicotinamide adenine dinucleotide (NADH) in the cell.
Owner:WISCONSIN ALUMNI RES FOUND

Label-Free Single and Multi-Photon Fluorescence Spectroscopy to Detect Brain Disorders and Diseases: Alzheimer, Parkinson, and Autism From Brain Tissue, Cells, Spinal Fluid, and Body Fluids

A label free single or multi-photon optical excitation fluorescence spectroscopy for measuring the differences between the levels of fluorophores from tryptophan, collagen, reduced nicotinamide adenine dinucleotide (NADH), and flavins exist in brain samples from a of Alzheimer's disease (AD) and in normal (N) brain samples with label-free fluorescence spectroscopy. Relative quantities of these molecules are shown by the spectral profiles of the AD and N brain samples at excitation wavelengths and multi photons about 266 nm, 300 nm, 400 nm and 500 nm. The emission spectral profile levels of tryptophan and flavin were much higher in AD samples, while collagen emission levels were slightly lower and NADH levels were much lower in AD samples. These results yield a new optical method for detection of biochemical differences in animals and humans for Alzheimer's disease. These molecules in AD and N tissues and cells can be excited by 1PEF, 2PEF, 3PEF, 4 PEF using fs and ps pulses
Owner:ALFANO ROBERT +1

Microsomal bioreactor for synthesis of drug metabolites

Reusable microsomal biocatalytic systems (bioreactors) constructed on carbon nanostructure modified electrodes are provided. The bioreactors comprise stable, biologically active immobilized enzymes such as human cytochromes P 450 (CYPs) and their redox partner proteins, e.g. CYP-NADPH (reduced nicotinamide adenine dinucleotide phosphate) reductases (CPR), on the carbon nanostructure surface. The immobilized enzymes may be present in liver microsomes, such as human liver microsomes (HLM) or as bactosomes, S9 fractions, etc. The bioreactors are used, for example, for synthesizing metabolites of interest from compounds such as drugs that are catabolized by the enzymes.
Owner:BOARD OF REGENTS FOR OKLAHOMA STATE UNIVERSITY

Fluorescent probe for detecting reduced nicotinamide adenine dinucleotide and phosphate ester of reduced nicotinamide adenine dinucleotide and preparation method and application of fluorescent probe

The invention discloses a preparation method of a fluorescent probe for detecting reduced nicotinamide adenine dinucleotide and phosphate ester of the reduced nicotinamide adenine dinucleotide. The method includes the following steps that 7-diethylamino coumarin and 1,2,3,3-tetramethyl-6-nitro-3H-indolium iodide are added into a reactor, absolute ethyl alcohol is added after vacuum / nitrogen replacement, hot reflux stirring is carried out on 10-15 hours under nitrogen protection, the reaction liquid is concentrated and evaporated, and a target compound is obtained by purifying the obtained solid through silica gel column chromatography. According to the method, the 7-diethylamino coumarin and the 1,2,3,3-tetramethyl-6-nitro-3H-indolium iodide serve as a fluorescent matrix, and on the basisof an H selective nucleophilic addition specific cyanine derivative on NAD(P)H, a whole conjugated system is changed, so that the pushing-drawing electron capacity in molecules is influenced, and selective detection of NAD(P)H is realized by utilizing the fluorescence wavelength difference between reactants and products.
Owner:ZHOUKOU NORMAL UNIV

NADH-containing (reduced nicotinamide adenine dinucleotide-containing) composition and preparation to improve climacteric symptoms and their preparation methods and applications

The invention discloses NADH-containing (reduced nicotinamide adenine dinucleotide-containing) composition and preparation to improve climacteric symptoms and their preparation methods and applications and relates to the field of medicine and health. The composition includes, by weight, 1-10 parts of NADH, 1-10 parts of secondary anhydroicaritin, 1-10 parts of chondroitin sulfate, 1-10 parts of ursodesoxycholic acid, 1-10 parts of sialic acid, 1-10 parts of S-adenosyl methionine, 1-10 parts of polygala root, 1-10 parts of DHA (docosahexaenoic acid), and 1-10 parts of gamma-aminobutyric acid. The components of the composition are in suitable ratio and can coact to all-directionally improve climacteric symptoms safely with no side effects. The preparation method of the preparation has a simple process flow, short process time and zero byproducts, is low in production cost and is easy to apply to large-scale production.
Owner:HOBOOMLIFE BIO TECH SHENZHEN CO LTD

Synthetic method of L-galactose

The invention discloses a synthesis method of L-galactose, which comprises the following steps: taking galactitol and oxidized nicotinamide adenine dinucleotide disodium salt, mixing, adding mannitol dehydrogenase and NADH oxidase, and reacting to generate L-galactose; or taking and mixing D-galactose and reduced nicotinamide adenine dinucleotide disodium salt, adding mannitol dehydrogenase and D-galactose reductase for a reaction, and generating L-galactose. According to the method, cheap and bulk D-galactose or galactitol in the market is adopted as a raw material, and expensive L-galactose is obtained through one-step or two-step direct conversion by utilizing an enzyme catalyst. The preparation scheme has multiple industrial application advantages, the used raw materials are cheap, the preparation route is short, the reaction conditions are simple, and the waste emission is low; and the characteristics well meet the basic requirements of current green industrial production.
Owner:SOUTH CHINA NORMAL UNIVERSITY

Kit for detecting D-psicose and detection method

The invention provides a kit for detecting D-psicose and a detection method, and relates to the technical field of detection. The kit comprises a reagent I, a reagent II, a reagent III, a reagent IV and a reagent V. The reagent I is a phosphate buffer solution, the main component of the reagent II is reduced nicotinamide adenine dinucleotide (NADH), the main component of the reagent III is ribitol dehydrogenase, and the main component of the reagent IV is D-psicose. By utilizing the kit, 96 samples can be detected within 30 minutes, and the concentration or content of D-psicose in the samples can be quickly and accurately reflected. The kit is not influenced by interferents such as D-fructose and other monosaccharides in the detection process, and can be applied to detection of the conversion amount of D-fructose to D-psicose in the KEase enzymatic reaction process and screening of KEase enzyme variants. In the detection process by using the kit, large-scale instruments and equipment are not needed, so that the detection cost can be remarkably reduced.
Owner:TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY +1

Gene-encoded nicotinamide adenine dinucleotide fluorescent probe and its preparation method and application

The invention relates to a fluorescent probe encoded by nicotinamide adenine dinucleotide gene and its preparation method and application. On the one hand, the present invention relates to a detection probe for nicotinamide adenine dinucleotide, in particular to a detection probe for a recombinant fluorescent fusion protein of nicotinamide adenine dinucleotide. In one specific aspect, the present invention relates to a recombinant fluorescent fusion protein detection probe of reduced nicotinamide adenine dinucleotide (NADH); in another specific aspect, the present invention relates to oxidized nicotinamide adenine dinucleotide (NADH) NAD+) recombinant fluorescent fusion protein detection probe; In yet another aspect, the present invention relates to a recombinant fluorescent fusion protein detection probe for the ratio of reduced and oxidized nicotinamide adenine dinucleotides. The present invention also relates to the preparation method of the above detection probe and its application in detecting NADH, NAD+ and NADH / NAD+ ratio respectively.
Owner:EAST CHINA UNIV OF SCI & TECH

Detection method for early-stage hepatocellular injury diagnosis

The invention discloses a detection method for early-stage hepatocellular injury diagnosis. The detection method comprises the steps of preparing a sample, preparing a kit, determining the sample, and calculating a GR energy value in the sample, wherein reduced nicotinamide adenine dinucleotide phosphate (NADPH) is adopted for donating hydrogen; GR can catalyze oxidized form glutathione (GSSG) for reducing to generate reduced glutathione (GSH); the NADPH has intensive light absorption at a 340nm wavelength part; the NADPH is oxidized to NADP<+> during reaction, the light absorption degree at the 340nm wavelength part is reduced, and the reduction rate is in direct proportion to the activity of the GR in the sample, so that an activity level of the GR can be calculated through determining the reduction rate of A340; the detection method is a simple and practicable method for detecting the GR activity in serum, plasma or other samples through an ultraviolet enzyme method, and is high in sensitivity and good in stability.
Owner:江西乐成生物医疗有限公司

Label-free single and multi-photon fluorescence spectroscopy to detect brain disorders and disease: alzheimer, parkinson and autism from brain tissue, cells, spinal fluid and body fluids

A label free single or multi-photon optical spectroscopy for measuring the differences between the levels of fluorophores from tryptophan, collagen, reduced nicotinamide adenine dinucleotide (NADH), and flavins exist in brain samples from a of Alzheimer's disease (AD) and in normal (N) brain samples with label-free fluorescence spectroscopy. Relative quantities of these molecules are shown by the spectral profiles of the AD and N brain samples at excitation wavelengths 266 nm, 300 nm, and 400 nm. The emission spectral profile levels of tryptophan and flavin were much higher in AD samples, while collagen emission levels were slightly lower and NADH levels were much lower in AD samples. These results yield a new optical method for detection of biochemical differences in animals and humans for Alzheimer's disease.
Owner:ALFANO ROBERT +1

Enzyme capable of dehydroxylating hydroxyl group in urolithin compound

An object of the present disclosure is, at least, to provide an enzyme that dehydroxylates hydroxyl groups at predetermined positions of urolithins having hydroxyl groups at the predetermined positions, and the object can be solved by an enzyme having the following properties (1) and (2): (1) dehydroxylating a hydroxyl group at the 4-position of urolithins; and (2) in the presence of methyl viologen (MV), being activated by one or more components selected from the group consisting of: reduced nicotinamide adenine dinucleotide (NADH); reduced nicotinamide adenine dinucleotide phosphate (NADPH); flavin adenine dinucleotide (FAD); and flavin adenine mononucleotide (FMN).
Owner:DAICEL CHEM IND LTD

Use of nadph in preparing medicines for treatment of heart diseases

The use of reduced nicotinamide adenine dinucleotide phosphate (NADPH) in preparing medicines for the treatment of heart diseases, and medicines for the treatment of heart diseases using NADPH as the active ingredient, said heart diseases including cardiac damage, myocardial infarction, and cardiomyopathy.
Owner:CHONGQING INST OF BENCH TO BED BIOENG TECH CO LTD

Culture medium additive for improving content of organic selenium in selenium yeast

ActiveCN112553093AImprove the ability to transform inorganic selenium into organic seleniumReduce peroxidative damageFungiChemical cell growth stimulationFructoseHIGH SELENIUM YEAST
The invention discloses a culture medium additive for improving the content of organic selenium in selenium yeast, and belongs to the technical field of selenium yeast. The culture medium additive consists of the following components: 1000 mg / L of reduced glutathione (GSH), 100 mg / L of reduced nicotinamide adenine dinucleotide tetrasodium phosphate (NADPH-Na4), 40 g / L of fructose and 400-800 mg / Lof ATP. Orthogonal experiments are carried out on the addition amounts of the four culture medium additives, and through the experiments, it finds that the selenium-enriched yeast obtained by adding the additive into the culture medium has the characteristics of high biomass, high selenium enrichment, high organic selenium conversion, high yield and the like, and the problem that the conversion amount of organic selenium in the selenium-enriched yeast is small is effectively solved.
Owner:安徽省华信生物药业股份有限公司

Preparation method of reduced nicotinamide adenine dinucleotide

The invention relates to the technical field of industrial catalysis, in particular to a preparation method of reduced nicotinamide adenine dinucleotide, which comprises the following steps: 1) screening the activity of formate dehydrogenase at high temperature; 2) screening the activity of formate dehydrogenase under an acidic condition; (3) according to the results of the step (1) and the step (2), formate dehydrogenase with relatively high activity under a high-temperature condition and an acidic condition is selected for later use; respectively weighing ammonium formate and NAD (Nicotinamide Adenine Dinucleotide) into a flask, adding pure water, stirring and dissolving in a water bath, and regulating the pH to be acidic by using sodium hydroxide; finally, formate dehydrogenase obtained through screening is added for reaction, sodium hydroxide is used for maintaining the pH value to be acidic, and the reduced nicotinamide adenine dinucleotide is prepared. According to the method, the reaction can be completed in a short time, so that hydrolysis of a product under an acidic condition is avoided, and carbonate generated under an alkaline condition is also avoided; after the reaction, no large amount of carbonate exists, and the purification cost is low.
Owner:NANJING NUOYUN BIOLOGICAL TECH CO LTD

Method for quickly evaluating influence degree of organic acid level for alcohol metabolism of Maotai-flavour liquor

The invention discloses a method for quickly evaluating an influence degree of an organic acid level for alcohol metabolism of Maotai-flavour liquor. The method comprises the following steps of: S1: preparing mixed liquor; S2: adding 5[mu]L of 0.0075mg / [mu]L of ethyl alcohol dehydrogenase liquid into the mixed liquor, after incubation is carried out, using a spectrograph to measure a light absorption value under a condition of 340mm wavelength to obtain a [delta]A determination tube; S3: defining the activity of ethyl alcohol dehydrogenase that at the temperature of 25 DEG C, an enzyme quantity required for each 1mL of acid solution to oxidize 1[mu] mol of coenzyme I in each 1min to generate 1[mu] mol of reduced nicotinamide adenine dinucleotide is one enzyme activity unit, and a following calculation formula is obtained: ADH([mu]mol / min / mL)=[([delta]A determination tube-[delta]A empty tube) / [epsilon] / d*V reaction total volume*10<6>] / V sample adding quantity / T; and S4: according to the above formula, analyzing the activity of the ethyl alcohol dehydrogenase under different concentrations of different organic acids. Through the above formula, the method disclosed by the invention calculates the activity of the ethyl alcohol dehydrogenase under different concentrations of different categories of organic acids, the influence degree of an organic acid level for after-drinking alcohol metabolism can be evaluated.
Owner:贵州国台酒业集团股份有限公司 +1

Method for improving performance of flexible photoelectric detector

According to the method for improving the performance of the flexible photoelectric detector, the characteristic that reduced nicotinamide adenine dinucleotide phosphate (NADPH) has high reducibility is utilized, and the reduced nicotinamide adenine dinucleotide phosphate (NADPH) serves as an additive to be used in the preparation process of solid electrolyte, so that the performance of the flexible photoelectric detector is improved. When incident light irradiates on the photoelectric detector, NADPH as an efficient hole transfer medium can effectively inhibit recombination of electron holes in an electrochemical system. According to the method, the NADPH is used as the additive for improving the performance of the flexible photoelectric detector for the first time, the photocurrent density of the device can be remarkably improved, the manufacturing process is simple, the cost is low, the method can be used for large-scale preparation, and the application prospect of the device is further widened.
Owner:XIANGTAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products